J. K. Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.50 M
as on 07-12-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -7.74%
(FY 2022)
- Ebitda 12.24%
(FY 2022)
- Net Worth -11.38%
(FY 2022)
- Total Assets 1.40%
(FY 2022)
About J. K. Biotech
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kuljit Arora, Karansingh Arora, Vikramsingh Jagmohansingh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900MH2007PLC173698
- Company No.
173698
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at J. K. Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuljit Arora  | Director | 31-Aug-2007 | Current |
| Karansingh Arora | Director | 31-Aug-2007 | Current |
| Vikramsingh Jagmohansingh | Director | 10-Jan-2022 | Current |
| Arjun Arora | Director | 10-Jan-2022 | Current |
| Jagmohan Arora | Director | 31-Aug-2007 | Current |
Financial Performance of J. K. Biotech.
J. K. Biotech Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J. K. Biotech?
In 2018, J. K. Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Dwarkadhis Marble Mining Private LimitedActive 28 years 12 daysKuljit Arora, Vikramsingh Jagmohansingh and 1 more are mutual person
Satguru Minchem Private LimitedActive 12 years 3 monthsKaransingh Arora and Vikramsingh Jagmohansingh are mutual person
Satguru Granites Private LimitedActive 12 years 3 monthsVikramsingh Jagmohansingh, Arjun Arora and 1 more are mutual person
Gelda Marbles Private LimitedActive 26 years 5 monthsKuljit Arora, Vikramsingh Jagmohansingh and 1 more are mutual person
Drill Well Cement Private LimitedActive 14 years 1 monthKaransingh Arora, Vikramsingh Jagmohansingh and 1 more are mutual person
Composite Mining Private LimitedActive 12 years 3 monthsKaransingh Arora and Vikramsingh Jagmohansingh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at J. K. Biotech?
Unlock and access historical data on people associated with J. K. Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. K. Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. K. Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.